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Background: Post-operative anastomotic insufficiency following major hepato-biliary surgery has significant impacts
on the post-operative course. Recent reports have revealed that platelets play an important role in liver regeneration
and wound healing. From these experimental and clinical results on platelet function, we hypothesized that
post-operative platelet depletion (to <10 × 104/μL) would be associated with delayed liver regeneration as well as
anastomotic insufficiency of intrahepatic cholangiojejunostomy. However, little information is available regarding
correlations between platelet count and these complications. The purposes of the present study were, firstly, to
evaluate the incidence of anastomotic insufficiency following intrahepatic cholangiojejunostomy and, secondly,
to evaluate whether platelet depletion represents a risk factor for anastomotic insufficiency in intrahepatic
cholangiojejunostomy.
Methods: Participants in this study comprised 220 consecutive patients who underwent intrahepatic
cholangiojejunostomy following hepato-biliary resection for biliary malignancies between September 1998 and
December 2010. Anastomotic insufficiency was confirmed by cholangiographic demonstration of leakage from
the anastomosis using contrast medium introduced via a biliary drainage tube or prophylactic drain placed
during surgery.
Results: Anastomotic insufficiency of the intrahepatic cholangiojejunostomy occurred in 13 of 220 patients (6%).
Thirteen of the 220 patients, including one with anastomotic insufficiency, died during the study. Uni- and multivariate
analyses both revealed that platelet depletion on post-operative day 1 (<10 × 104/μL) correlated with anastomotic
insufficiency.
Conclusion: Post-operative platelet depletion was closely associated with anastomotic insufficiency following
intrahepatic cholangiojejunostomy. This correlation has been established, but the underlying mechanisms have not.
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Liver resection with intrahepatic cholangiojejunostomy
for biliary malignancies is one of the most demanding
surgeries and is associated with a high morbidity rate.
Recent reports have revealed post-operative morbidity
rates ranging from 42% to 59% [1-6]. Morbidity is high
because the operations comprise various difficult and
highly technical procedures. We have previously re-
ported that the most frequent post-operative complica-
tions are organ/space surgical-site infection (SSI), liver
failure, respiratory complications, and anastomotic insuf-
ficiency of the intrahepatic cholangiojejunostomy [7].
In general, intrahepatic cholangiojejunostomy is thought
to be more technically demanding than hepaticojejunost-
omy. Previous reports have therefore shown that the
incidence of anastomotic insufficiency after intrahepatic
cholangiojejunostomy (6.8-50%) is higher than that after
hepaticojejunostomy (0.4-8%) [4,8-12]. Several studies
have reported on bile leakage after intrahepatic cholangio-
jejunostomy, but those did not clearly specify whether the
bile leak arose from the liver stump or from the site of
anastomosis for the hepaticojejunostomy, as Nagino et al.
suggested in their previous report [9]. Precise determin-
ation of the incidence of, and risk factors for, anastomotic
insufficiency after intrahepatic cholangiojejunostomy re-
mains difficult.
Recent experimental studies have suggested that blood
platelets play a pivotal role in liver regeneration after
partial liver resection [13-16]. A depleted platelet count
severely suppresses liver regeneration, whereas induction
of thrombocytosis by administration of thrombopoietin or
splenectomy has been shown to accelerate liver
regeneration [14-16]. Some evidence also suggests that
platelet-derived serotonin plays an essential role in
platelet-mediated liver regeneration [16]. In addition,
several clinical studies have revealed that platelet
counts below 10 × 104/μL pre-operatively and immedi-
ately post-operatively are associated with an increased
risk of mortality and delayed recovery of liver function
after partial liver resection [17-19]. Experimental evi-
dence has also shown that bile duct cells regenerate
along with other hepatocytes [20]. Other recent experi-
mental studies have concluded that platelets play
important roles in not only liver regeneration, but also
tissue repair [21,22]. Given these results regarding
platelet functions, we hypothesized that post-operative
platelet depletion (to <10 × 104/μL) would be associated
with delayed liver regeneration and anastomotic insuffi-
ciency after intrahepatic cholangiojejunostomy. How-
ever, data for this hypothesis are lacking. The purpose
of this study was therefore to evaluate whether post-
operative depletion of platelets was associated with
anastomotic insufficiency following intrahepatic cholan-
giojejunostomy. The primary outcome parameter wasincidence of anastomotic insufficiency with intrahepatic
cholangiojejunostomy. We performed uni- and multivari-
ate analyses to identify both clinical variables associated
with anastomotic insufficiency and clinical factors corre-
lated with platelet depletion in the post-operative period.
Methods
Study participants
Participants comprised 220 consecutive patients who
underwent intrahepatic cholangiojejunostomy following
hepato-biliary resection for biliary malignancies from
September 1998 and December 2010.
Pre-operative biliary drainage
All hepatectomies were performed after the total biliru-
bin concentration had decreased to below 2 mg/dL.
Pre-operative biliary decompression was performed to
reduce serum bilirubin concentration to below 2 mg/dL
for all patients with jaundice, and to control segmental
cholangitis.
Pre-operative portal vein embolization (PE)
Pre-operative PE of the liver was performed when right
trisegmentectomy, right hepatectomy, or left trisegmen-
tectomy was planned. Indications and procedures for PE
have been described previously [23].
Surgery
Hepatectomies were classified according to the Brisbane
2000 Terminology [24]. Hepatoduodenal ligament skele-
tonization, lymphadenectomy, and various hepatecto-
mies with en bloc resection of the caudate lobe and
extrahepatic bile duct were performed. Details of these
procedures have been described previously [7].
Our procedure for bilioenteric anastomosis using the
Roux-en-Y jejunal limb has been described previously with
video [25]. Briefly, the jejunal limb was brought to the
hepatic ducts via the standard retrocolic-anteduodenal
route. In the case of hepatic pancreatoduodenectomy, re-
construction was performed according to Child’s method
with an end-to-side pancreaticojejunostomy. All cholan-
giojejunostomies were performed by anastomosing the
mucosal layers of the bile duct and intestine. Transanasto-
motic stents were placed in all patients, usually introduced
via a trans-jejunal route or occasionally a transhepatic
route. Although most bile ducts to be anastomosed were
drained by percutaneous transhepatic biliary drainage, a
trans-jejunal route rather than a transhepatic route was
preferred because the sinus tract between the liver and ab-
dominal wall was usually broken at laparotomy.
Drains were placed prophylactically near the anasto-
mosis and the cut surface of the liver. Until the end of
2004, Penrose drains were used along the hepatic stump.
Table 1 Subject characteristics
Subject characteristics Number of
subjects
Age (years) median: 68 >68 126
Sex Male/Female 146/74
Preoperative diagnosis BDC 140
GBC 35
ICC 45
Body mass index; median: 22 <22 105
Diabetes mellitus Positive 39
ICGR15 > 10% Yes 129
ICGR15 > 15% Yes 37




Preoperative portal vein embolism Yes 114











Vascular combined resection Hepatic artery 24
Portal vein 118
Number of bile duct reconstructions;
median: 3
≥3 139
Blood transfusion Yes 84
Post-operative max
AST (IU); median: 443
>440 110
Post-operative max
ALT (IU); median: 372
>370 110
Platelet count (pre-operative period) <12 × 104/μL 6
Platelet count (post-operative day 1) <10 × 104/μL 30
BDC: extrahepatic cholangiocarcinoma, GBC: gallbladder cancer, ICC: intrahepatic
cholangiocarcinoma, ICGR15: indocyanine green retention rate at 15 min, ENBD:
endoscopic nasobiliary drainage, PTBD: percutaneous transhepatic biliary
drainage, Right: right extended hepatectomy, Left: left extended hepatectomy,
max: maximum, AST: aspartate aminotransferase, ALT: alanine aminotransferase.
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in the same spaces.
Definitions of post-operative complications
Post-operative complications were graded according to
the Clavien-Dindo classification [26]. Anastomotic insuf-
ficiency of intrahepatic cholangiojejunostomy was identi-
fied by cholangiographic demonstration of leakage from
the anastomosis using contrast medium introduced via a
biliary drainage tube or prophylactic drain placed during
surgery [9]. This procedure allowed us to differentiate
between an anastomotic leak and bile leaking from the
liver stump.
Organ/space SSI was defined as follows: with intra-
abdominal collections; drain/s left in place for more
than 3 weeks; patients with severe complications such
as sepsis requiring admission to the intensive care unit;
hemorrhage needing interventional radiology; or repeat
laparotomy. In this group, pancreatic- or bile-related
infectious complications were also included. Patients
with organ/space SSI did not include those with anasto-
motic insufficiency. Post-operative liver failure was de-
fined as International Study Group of Liver Surgery
(ISGLS) liver failure grade B/C [27].
Statistical analysis
Statistical analyses were performed using the Mann–
Whitney U test, a χ2 test, or Fisher’s exact test and the
Kruskal-Wallis test. Values of p <0.05 were considered sta-
tistically significant. All variables reaching a p-value of less
than 0.1 in univariate analysis were included in a multi-
variate analysis using a logistic step-by-step regression
model. Results are presented as odds ratios (ORs) with
95% confidence intervals (CIs).
Informed consent
The need to obtain informed consent for participation in
this retrospective study was waived by the institutional
review board.
Statements
We confirm that all study protocols were approved by
ethics committee of Hokkaido University Hospital.
Results
A total of 220 patients (146 men, 74 women) were en-
rolled, comprising 140 with extra-hepatic bile duct can-
cer, 45 with intrahepatic cholangiocarcinoma, and 35
with gallbladder carcinoma. Median age was 68 years
(range, 41–81 years).
Pre- and post-operative patient characteristics are pre-
sented in Table 1. Median operation time was 647 min
(range, 415–1180 min) and median estimated blood losswas 1783 mL (range, 510–24,520 mL). The median num-
ber of reconstructed bile ducts was 3 (range, 1–5).
Anastomotic insufficiency of the intrahepatic cholan-
giojejunostomy occurred in 13 (6%) of the 220 patients.
Other post-operative complications are shown in Table 2.
All instances of anastomotic leakage were treated con-
servatively, by maintenance of a drain that had been
placed prophylactically near the cholangiojejunostomy
during surgery. One patient died due to post-operative
liver failure following anastomotic insufficiency.
Table 2 Postoperative complications
Postoperative complication Number of subjects
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(to <10 × 104/μL on post-operative day (POD)1) was asso-
ciated with anastomotic insufficiency. According to uni-
variate analysis, platelet depletion was associated with
anastomotic insufficiency (p < 0.01), but post-operative
liver failure was not. Multivariate analyses revealed that
platelet count <10 × 104/μL on POD1 was a significant
predictor of anastomotic insufficiency. Vascular combined
resection (portal vein and/or hepatic artery) was not asso-
ciated with anastomotic insufficiency (Table 3).
Finally, we examined clinical factors correlated with
platelet count <10 × 104/μL on POD1. According to
univariate analysis, platelet counts <10 × 104/μL on
POD1 were closely associated with pre-operative plate-
let count <12 × 104/μL (below the institutional lower
limit of normal), operative blood loss >1700 mL, acti-
vated partial thromboplastin time (APTT) on POD1 >
40 s, and post-operative organ/space SSI. Among these
clinical factors, pre-operative platelet count, operative
blood loss, and APTT on POD1 were significant inde-
pendent predictors of platelet count <10 × 104/μL on
POD1 in multivariate analysis (Table 4).
We verified that patients with pre-operative platelet
depletion did not show any significant differences in pre-
operative liver functions (prothrombin time-international
normalized ratio (PT-INR) or indocyanine green retention
rate at 15 min (ICGR-15)). No patients with severe sepsis
and platelet depletion underwent hepatectomy.
Discussion
This study found a 6% incidence of anastomotic insuf-
ficiency following intrahepatic cholangiojejunostomy
and also revealed that post-operative platelet depletion
(to <10 × 104/μL on POD1) might be associated with in-
creased risk of anastomotic insufficiency.The incidence of anastomotic insufficiency following
intrahepatic cholangiojejunostomy is thought to be higher
than that with hepaticojejunostomy. Nagino et al. pro-
posed that this was because the bile duct is small and
fragile, and multiple anastomoses are often necessary.
However, their surgical results for intrahepatic cholangio-
jejunostomy were suitable, with an anastomotic insuffi-
ciency rate of 6.4% (3.6% in the later period with increased
experience) [9]. Our operative results with intrahepatic
cholangiojejunostomy (anastomotic insufficiency rate, 6%)
also appear suitable. Furthermore, Nagino et al. suggested
that intra-operative massive hemorrhage or patient age
were more closely associated with anastomotic insuffi-
ciency than the number of bile ducts reconstructed [9].
The present study identified a different risk factor for
anastomotic insufficiency: post-operative platelet deple-
tion. Our data showed operative blood loss >1700 mL
was associated with post-operative platelet depletion on
univariate analysis (Table 4). Previous results from
Nagino et al. that intra-operative massive hemorrhage
was associated with anastomotic insufficiency might thus
be explained by post-operative platelet depletion [9].
A potentially important determinant of anastomotic in-
sufficiency due to poor wound healing is blood supply,
which for the bile ducts are accomplished mainly by the
arterial system. We hypothesize that concomitant hepatic
artery resection and reconstruction might have been asso-
ciated with anastomotic insufficiency of intrahepatic cho-
langiojejunostomy, because these cases had risk factors for
thrombosis. Our series included no cases with hepatic ar-
tery obstruction in the post-operative period, and our data
showed no correlation with hepatic artery combined re-
section or anastomotic insufficiency (Table 4).
Recent clinical studies have revealed that platelet deple-
tion in the pre- and post-operative periods is associated
with delayed liver regeneration [17], and the present data
support this.
Alkozai et al. noted that patients with a low immediate
post-operative platelet count (<10 × 104/μL) displayed
worse post-operative liver function. A low platelet count
immediately post-operatively was identified as an inde-
pendent risk factor for delayed post-operative recovery of
liver function [17]. Liver regeneration means not only re-
generation of hepatocytes, but also endothelial cells, Kupf-
fer cells, and bile duct cells. Indeed, experimental evidence
has suggested that bile duct cells regenerate along with
other hepatocytes [20]. Post-operative platelet count may
thus be directly related to recovery at the anastomotic site
after intrahepatic cholangiojejunostomy.
The mechanism by which platelets participate in liver
regeneration may work as follows: contact between platelets
and hepatocytes initiates signal transduction involved in
growth factor activation. Hepatocyte growth factor (HGF),
vascular endothelial growth factor (VEGF), and insulin-like
Table 3 Possible risk factors for anastomotic insufficiency following intrahepatic cholangiojejunostomy
Univariate analysis Multivariate analysis
Subject characteristics Anastomotic
insufficiency (n =13)
P Odds ratio 95% CI P
Age (years) 68 > (n =102) 7 1
Sex Male (n =146) 9 1
Female (n =74) 4
BMI <22 (n =109) 3 0.083 NS
>25 (n =33) 1 0.697
Diabetes mellitus Positive (n =39) 2 1
ICGR15 (%);
median: 10
>10 (n =129) 8 1
>15 (n =38) 3 0.475
Preoperative biliary drainage ENBD (n =110) 4 0.262
PTBD (n =64) 6
None (n =46) 3
Preoperative portal vein embolism Yes (n = 114) 5 0.396
Preoperative PT-INR; median: 1.1 >1.1 (n =75) 4 1
Preoperative albumin
(mg/dL)
<3.9 (n = 112) 7 1




Other (n =2) 0
PD Yes (n =30) 0 0.224
Operative blood loss (mL) >1700 (n =108) 7 0.781
>3000 (n =34) 3 0.429
>5000 (n =13) 2 0.174
Operation time (min) >660 (n =103) 6 1
Vascular combined resection Hepatic artery (n =24) 2 0.639
PV (n =118) 7 1
Number of bile duct reconstructions ≥3 (n =139) 9 0.772
Postoperative max AST (IU) >440 (n =110) 9 0.251
Postoperative max ALT (IU) >370 (n =110) 8 0.569
Platelet count (POD1) <10 x 104/μL (n =30) 5 0.020 3.63 1.15-13.01 0.029
PT-INR (POD1); median: 1.8 >1.8 (n =105) 5 0.769
APTT (POD1); median: 40 >40 (n =107) 6 1
Postoperative liver failure Yes (n =28) 3 0.198
BMI: body mass index, DM: diabetes mellitus, ENBD: endoscopic nasobiliary drainage, PTBD: percutaneous transhepatic biliary drainage, PT-INR: prothrombin
time-international normalized ratio, PV: portal vein, ICGR: indocyanine green retention rate at 15 min, PD: pancreaticoduodenectomy, AST: aspartate amino
transferase, ALT: alanine aminotransferase, POD: postoperative day, N.S: no statistically significant difference.
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proliferation [2].
Other recent experimental studies have concluded that
platelets play an important role in not only liver regener-
ation, but also tissue repair mechanisms [21,22]. At least
60 different biologically active substances in platelets are
involved in tissue-repair mechanisms such as chemotaxis,
cell proliferation and differentiation, angiogenesis,intracellular matrix deposition, immune modulation, anti-
micro-bial activity, and remodeling. Among these, growth
factors (epidermal growth factor, platelet-derived growth
factor, transforming growth factor alpha, and transforming
growth factor beta) are thought to be the most important
[22]. Platelet-rich plasma (PRP) has long been used as a
source of platelet-related growth factors [21,22]. Several
studies using animal models have shown that PRP
Table 4 Correlation between platelet depletion on POD1 and clinical characteristics
Subject characteristics Univariate analysis Multivariate analysis






Age (years) >68 19 0.553
BMI <22 10 0.116
Diabetes mellitus Yes 8 0.197
ICGR-15 >10% 21 0.231
>15% 7 0.430
Pre-operative albumin (mg/dL) <3.9 16 0.845
Pre-operative platelet count <12 × 104/μL 5 <0.01 34.7 3.16-380.2 <0.01
Preoperative Portal vein embolism Yes 20 0.716
Type of hepatectomy Right/trisegmen-tectomy 21 0.542
PD Yes 3 0.775
Operative blood loss (mL) >1700 24 <0.01 5.24 1.69-16.2 <0.01
Operation time (min) >660 21 1
Concomitant resection Hepatic artery 5 0.339
PV 12 0.432
Number of bile duct reconstructions >3 14 0.065 - - N.S
Postoperative AST (IU) >370 15 1
Postoperative ALT (IU) >440 16 0.844
PT-INR (POD1) >1.8 18 0.171
APTT (POD1) >40 26 <0.01 5.31 1.71-16.46 <0.01
Organ/space SSI (n =30) Yes 9 <0.01 - - N.S
POD1: post-operative day 1, BMI: body mass index, ICGR-15: indocyanine green retention rate at 15 min), PV: portal vein, Right: right extended hepatectomy,
PD: pancreaticoduodenectomy, AST: aspartate amino transferase, ALT: alanine aminotransferase, PT-INR: prothrombin time-international normalized ratio,
APTT: activated partial thromboplastin time, SSI: surgical-site infection, N.S: no statistically significant difference.
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and increased vascularity after intestinal or bronchial
anastomosis [28,29].
The above experimental evidence, along with clinical
data (including the present findings), supports the hy-
pothesis that post-operative platelet depletion is closely
associated with anastomotic insufficiency following intra-
hepatic cholangiojejunostomy. Various mechanisms have
been thought to be associated with post-operative platelet
depletion. Post-operative platelet depletion was commonly
attributed to severe systemic infection with disseminated
intravascular coagulation or massive hemorrhage. Our
data showed that infectious complications were not as-
sociated with post-operative platelet depletion (on multi-
variate analysis), and none of our patients showed sepsis
during the early post-operative period (data not shown).
Our data do not rule out the possibility that post-
operative platelet depletion is associated with intra-
operative hemorrhage.
A few limitations to this study must be considered
when interpreting our findings. One problem was thelimited number of patients with anastomotic insuffi-
ciency (n = 13), which rules out identification of strong
correlations with any risk factor. A multi-institutional
database would allow further discussion of the risk fac-
tors for anastomotic insufficiency after hepatic resection
for cholangiocarcinoma. However, the present findings
represent a first step toward such a multi-institutional
study to clarify the risk factors for anastomotic insuffi-
ciency following intrahepatic cholangiojejunostomy.
Another problem was that our present study was lim-
ited by its retrospective design. We also cannot fully ex-
clude the possibility that patients with a low platelet
count on POD1 were simply in a worse general condition,
and therefore showed delayed recovery of liver regener-
ation or a greater incidence of anastomotic insufficiency
than patients with normal platelet counts. However, we
could not identify any significant differences between pa-
tients with and without pre-operative platelet depletion in
terms of pre-operative liver function (PT-INR or ICGR-
15). The reasons for the association between pre-operative
platelet depletion and anastomotic insufficiency following
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The point clearly identified by our data was that pre-
operative platelet depletion and intra-operative massive
hemorrhage were both closely associated with post-
operative platelet depletion, and post-operative platelet
depletion was a significant cause of anastomotic insuffi-
ciency following intrahepatic cholangiojejunostomy.
If platelet depletion was a significant cause of anasto-
motic insufficiency following intrahepatic cholangiojeju-
nostomy, one potential strategy could be to deliberately
increase the platelet count during the early post-operative
period. However, the current findings should not be
seen as a recommendation for more liberal use of plate-
let concentrates from blood donors, as several studies
have shown that platelet transfusion is associated with
increased risks of post-operative morbidity and mortal-
ity [30-32]. In contrast to endogenous platelets, plate-
lets from blood donors are frequently in an activated
state and may induce a range of inflammatory reactions
and unwanted side effects [33,34]. New strategies for
increasing platelet count safely or for the use of growth
factors associated with wound healing and liver regen-
eration are thus needed. One possible strategy is the
use of PRP to decrease anastomotic insufficiency. How-
ever, before clinical applications can be seriously contem-
plated, further investigation is needed to clarify whether
PRP is useful for reducing the incidence of anastomotic
insufficiency following intrahepatic cholangiojejunostomy.
Given our findings and the results from Nagino et al.,
minimizing intra-operative hemorrhage is important [9].
Conclusion
The incidence of anastomotic insufficiency following
intrahepatic cholangiojejunostomy was 6% in this sin-
gle, high-volume center experience.
Post-operative platelet depletion (to <10 × 104/μL on
POD1) was associated with anastomotic insufficiency
following intrahepatic cholangiojejunostomy, but fur-
ther experimental and clinical studies are needed to
elucidate the underlying mechanisms and clarify cor-
relations between platelet count and intrahepatic cho
langiojejunostomy.
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